Evaluation of sialic acid levels in patients with hydatidiform mole: a preliminary study
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2016Author
Özcan, Hüseyin ÇağlayanÖztürk, Ebru
Sucu, Seyhun
Uğur, Mete Gürol
Kutlar, İrfan
Balat, Özcan
Erbağcı, Binnur
Metadata
Show full item recordCitation
Özcan, H. Ç., Öztürk, E., Sucu, S., Uğur, M. G., Kutlar, İ., Balat, Ö. ve Erbağcı, B. (2016). Evaluation of sialic acid levels in patients with hydatidiform mole: a preliminary study. Clinical and Experimental Obstetrics & Gynecology, 43(3), 414-416. https://dx.doi.org/10.12891/ceog2156.2016Abstract
Purpose of investigation: This study aims to investigate whether hydatidiform mole (HM) disease with malignant potential is significantly associated with increased sialic acid (SA) levels. Materials and Methods: A total of 114 women were enrolled in this study. Patients were divided into three groups including HM (Group 1, n=34), control group including non-pregnant healthy patients (Group 2, n=42), and another control group including healthy pregnant patients within 12 weeks of gestation (Group 3, n=38). Serum-free SA levels were measured. Results: There was a statistically significant difference in serum-free SA levels among the groups (p < 0.001). Patients with HM had significantly higher levels compared to the control groups. Conclusion: The present study results showed that there was a significant correlation between HM and serum SA level.
WoS Q Kategorisi
Q4xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q3Source
Clinical and Experimental Obstetrics & GynecologyVolume
43Issue
3Collections
- Makale Koleksiyonu [3649]
- PubMed İndeksli Yayınlar Koleksiyonu [4047]
- Scopus İndeksli Yayınlar Koleksiyonu [6283]
- WoS İndeksli Yayınlar Koleksiyonu [6432]